Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

| --- | --- |

None

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ZIMMER BIOMET HOLDINGS, INC.

	By:	/s/ Bryan Hanson
Dated: February 25, 2022		Bryan Hanson
		Chairman, President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURE	TITLE	DATE
/s/ Bryan Hanson	Chairman, President and Chief Executive Officer	February 25, 2022
Bryan Hanson	(Principal Executive Officer)

/s/ Suketu Upadhyay	Executive Vice President and Chief Financial Officer	February 25, 2022
Suketu Upadhyay	(Principal Financial Officer)

/s/ Derek Davis	Vice President, Interim Controller and Chief Accounting	February 25, 2022
Derek Davis	Officer (Principal Accounting Officer)

/s/ Christopher Begley	Director	February 25, 2022
Christopher Begley

/s/ Betsy Bernard	Director	February 25, 2022
Betsy Bernard

/s/ Michael Farrell	Director	February 25, 2022
Michael Farrell

/s/ Robert Hagemann	Director	February 25, 2022
Robert Hagemann

/s/ Arthur Higgins	Director	February 25, 2022
Arthur Higgins

/s/ Maria Teresa Hilado	Director	February 25, 2022
Maria Teresa Hilado

/s/ Syed Jafry	Director	February 25, 2022
Syed Jafry

/s/ Sreelakshmi Kolli	Director	February 25, 2022
Sreelakshmi Kolli

/s/ Michael Michelson	Director	February 25, 2022
Michael Michelson

Previous: Item 15. Exhibits and Financial Statement Schedules